Building the future management of follicular lymphoma with T-cell–redirecting strategies
With the development of chimeric antigen receptor T-cell therapy and biologicals that engage both malignant B cells and normal T cells, the scene is set to
With the development of chimeric antigen receptor T-cell therapy and biologicals that engage both malignant B cells and normal T cells, the scene is set to
The filing shows Prospect had more than 100,000 creditors and between $1 billion and $10 billion in liabilities.
This cohort study assesses the incidence of KRAS mutations and their association with clinical outcomes based on the most common treatments used in patients with…
In this video, Rabi Hanna, MD, Cleveland Clinic, Cleveland, OH, comments on the promise of gene therapy approaches in the treatment of sickle cell disease…
Nujsaubnusi Vue, MD, shares reflections on the challenges, successes, and failures that she’s encountered thus far as an inaugural fellow.
I take a deep dive into the question: How much alcohol should a person drink?
Putting patients first even during crisis / cancer, City of Hope Comprehensive Cancer Center, OncoDaily, Oncology, Ravi Salgia, Sumanta K. Pal
At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or…
I take a deep dive into the question: How much alcohol should a person drink?
The FDA has approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult solid tumor nivolumab (Opdivo) indications.
Based on the pathophysiologic characteristics of venous thromboembolism (VTE), the inferior vena cava filter (IVC) should work. Placed between the proximal vessels of the lower…